Neutralizing Interleukin-4 Prevents Transplant Arteriosclerosis Mediated by Indirect Pathway T Cells Under CD40-CD154 Costimulation Blockade

被引:1
作者
Spriewald, Bernd M. [1 ]
Ensminger, Stephan M. [2 ]
Bushell, Andrew [3 ]
Wood, Kathryn J. [3 ]
机构
[1] Univ Erlangen Nurnberg, Dept Internal Med Hematol Oncol 5, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Ctr Cardiac Surg, D-91054 Erlangen, Germany
[3] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Transplantat Res Immunol Grp, Oxford OX3 9DU, England
基金
英国惠康基金;
关键词
Transplant arteriosclerosis; Vasculopathy; Costimulation; Aortic allograft; Indirect allorecognition; Interleukin-4; Eosinophil; Chronic rejection;
D O I
10.1097/TP.0b013e31818bbd3a
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction. Blockade of the CD40-CD154 costimulatory pathway can prolong allograft survival, but does not prevent the development of transplant arteriosclerosis in several models. In this study, we investigated the mechanisms of CD40-CD154-independent transplant arteriosclerosis in major histocompatibility complex (MHC)-class I-mismatched aortic allografts. Methods. MHC class I-mismatched CBK (H2(k) + K-b) donor aortas were transplanted into CBA (H2(k)) recipients who can only recognize the graft through CD8(+) T cells and CD4(+) T cells responding to the class I MHC mismatch through the indirect pathway of allorecognition. Recipients were treated with anti-CD154 antibody (MR1) alone or in combination with anti-CD8 (YTS169) or anti-interleukin (IL)-4 (11B11) antibodies. Grafts were analyzed by histology on days 30 and 60 and for intragraft mRNA expression on day 14 after transplantation. Results. Repeated treatment with anti-CD154 alone or in combination with anti-CD8 antibody did not prevent intimal proliferation compared with untreated controls (65%+/- 6%, 62%+/- 9%, and 71%+/- 7% luminal occlusion, respectively, 60 days after transplantation). In both treatment groups, the expression of IL-4, IL-5, and eotaxin was increased compared with control grafts, and an eosinophilic infiltration was observed. Neutralizing IL-4 in combination with CD40-CD154 blockade and CD8(+) T-cell depletion abrogated transplant arteriosclerosis (9%+/- 4% luminal occlusion 60 days after transplantation). Conclusion. Prolonged treatment with anti-CD154 was not able to prevent the development of transplant arteriosclerosis in MHC class I-mismatched aortic allografts, in the presence or absence of CD8(+) T cells. This CD40-CD154 pathway resistant transplant arteriosclerosis was mediated by IL-4, because neutralizing IL-4 in addition to CD40-CD154 costimulation blockade and CD8(+) T-cell depletion prevented its development.
引用
收藏
页码:1615 / 1621
页数:7
相关论文
共 47 条
[1]   Th1-Th2: reliable paradigm or dangerous dogma? [J].
Allen, JE ;
Maizels, RM .
IMMUNOLOGY TODAY, 1997, 18 (08) :387-392
[2]   A critical role for interleukin 4 in activating alloreactive CD4T cells [J].
Bagley, J ;
Sawada, T ;
Wu, Y ;
Iacomini, J .
NATURE IMMUNOLOGY, 2000, 1 (03) :257-261
[3]   The role of IL-4 and IL-12 in the regulation of collagen synthesis by fibroblasts [J].
Banning, Ursula ;
Krutmann, Jean ;
Koerholz, Dieter .
IMMUNOLOGICAL INVESTIGATIONS, 2006, 35 (02) :199-207
[4]  
Barks JL, 1997, J IMMUNOL, V159, P4532
[5]  
Bushell A, 1999, J IMMUNOL, V162, P1359
[6]   IN-VIVO DEPLETION OF CD8+ T-CELLS RESULTS IN TH2 CYTOKINE PRODUCTION AND ALTERNATE MECHANISMS OF ALLOGRAFT-REJECTION [J].
CHAN, SY ;
DEBRUYNE, LA ;
GOODMAN, RE ;
EICHWALD, EJ ;
BISHOP, DK .
TRANSPLANTATION, 1995, 59 (08) :1155-1161
[7]  
CORNACOFF JB, 1992, TOXICOL LETT, P64
[8]   Critical role of OX40 in CD28 and CD154-independent rejection [J].
Demirci, GI ;
Amanullah, F ;
Kewalaramani, R ;
Yagita, H ;
Strom, TB ;
Sayegh, MH ;
Li, XC .
JOURNAL OF IMMUNOLOGY, 2004, 172 (03) :1691-1698
[9]   THE ROLE OF CD40 IN THE REGULATION OF HUMORAL AND CELL-MEDIATED-IMMUNITY [J].
DURIE, FH ;
FOY, TM ;
MASTERS, SR ;
LAMAN, JD ;
NOELLE, RJ .
IMMUNOLOGY TODAY, 1994, 15 (09) :406-411
[10]   Indirect allorecognition can play an important role in the development of transplant arteriosclerosis [J].
Ensminger, SM ;
Spriewald, BM ;
Witzke, O ;
Pajaro, OE ;
Yacoub, MH ;
Morris, PJ ;
Rose, ML ;
Wood, KJ .
TRANSPLANTATION, 2002, 73 (02) :279-286